Candel Therapeutics Statistics
NASDAQ: CADLHealthcareBiotechnologyUSD
9.66-0.16 (-1.63%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Candel Therapeutics by the numbers
Candel Therapeutics has a market capitalization of $739.2 million based on 76.52M shares outstanding. With trailing EPS of $-1.46, Candel Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.7% below its 50-day average and 20.3% above its 200-day average.
Average daily trading volume is 1.21M shares, or about $11.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CADL valuation vs. peer median
| Metric | CADL | Peer median | Difference |
|---|---|---|---|
| Market cap | $739.17M | $739.52M | -0% |
| Avg. volume | 1.21M | 1.61M | -25% |
Peer median across 8 companies: ATTO, ANNX, DNA, VSTM, OABI, ARDX, NVCT, SLN.
Valuation
- Market cap
- $739.17M
- EPS (TTM)
- $-1.46
- Shares outstanding
- 76.52M
Price and trading
- Previous close
- 9.82
- Open
- 9.66
- Day range
- 9.45 – 9.76
- 52-week range
- 4.35 – 14.00
- 52-week change
- +53.33%
- Beta
- —
- Volume
- 888.41K
- Average volume
- 1.21M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 739.17M
- Forward Pe
- -15.46
- Eps
- -1.46
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.00
- Week52 Low
- 4.35
- Avg Volume
- 1.21M
- Shares Outstanding
- 76.52M
- Ma50
- 11.46
- Ma200
- 8.03
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -31.00%
- Pct From52w Low
- 122.07%